Esperion Therapeutics reported $252.48M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Amarin AMRN:US $ 719.12M 53.5M
Amgen AMGN:US $ 19322M 802M
Biogen BIIB:US $ 9740.9M 1825M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Cytokinetics CYTK:US $ 602.25M 21.28M
Daiichi Sankyo 4568:JP Y 1367130M 21859M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Esperion Therapeutics ESPR:US $ 252.48M 38.34M
Geron GERN:US $ 227.38M 51.45M
Halozyme Therapeutics HALO:US $ 541.94M 446.75M
Heron Therapeutics HRTX:US $ 194.21M 28.38M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
Intra Cellular Therapies ITCI:US $ 789.21M 59.14M
IONIS PHARMACEUT IONS:US $ 2191.15M 61.98M
Minerva Neurosciences NERV:US $ 50.04M 5.66M
Moderna Inc MRNA:US 13.56B 2.79B
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Ptc Therapeutics PTCT:US $ 694.68M 79.33M
Puma Biotechnology PBYI:US $ 114.28M 3.29M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Seattle Genetics SGEN:US $ 2778.66M 7.4M
United Therapeutics UTHR:US $ 2684.3M 97.7M
Vanda Pharmaceuticals VNDA:US $ 496.9M 4.63M